Novartis

News

Novartis focusing on cutting CAR-T costs ahead of EU launche...

Novartis is focusing on cutting manufacturing costs for its CAR-T cancer cell therapy as the company launches it across Europe, while keeping a watching brief on ‘off-the-shelf’ therapies t

News

Novartis' CAR-T cancer drug available on NHS to young people

Novartis’ cutting-edge CAR-T therapy Kymriah has officially become available on the NHS for young people with blood cancer.

News

Lilly files new class migraine drug with FDA

Eli Lilly has filed a new migraine drug, lasmiditan, with the US regulator, the first drug in its class to be reviewed as a treatment for the condition.

News

Eyeing Novartis deal, Akcea trumpets lipoprotein drug data

Ionis affiliate Akcea Pharma has new data for its antisense drug for elevated lipoprotein levels in patients with cardiovascular disease that it hopes will entice Novartis into a licensing deal.

News

Entresto tops mainstay ACE inhibitor in heart failure trial

Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope of revving up disappointing initial sales, and one of those trials has just delivered positiv

Partner Content